Trial · NCT03070600
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Maternal HIV Incidence | 6 weeks, 6 months, 9 months postpartum | Maternal HIV Incidence |
| Primary | Appropriate PrEP Decision | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Scored 1 for high risk women using PrEP and low risk women not using PrEP; 0 for high risk women NOT on PrEP and low risk women using PrEP |
| Secondary | PrEP Adherence | Enrollment to 9 months postpartum | Sequential dried blood spots, PrEP adherence by DBS dichotomous by pregnancy or postpartum thresholds equivalent to \~7 doses per week (≥650 fmol/punch during pregnancy or ≥950 fmol/punch postpartum) based on the thresholds established by the 2009 IMPAACT directly observed PrEP PK study. |
| Secondary | PrEP Duration | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Number of months on PrEP |
| Secondary | Partner With Known HIV Status | At 9 months postpartum | Participants report of partner's HIV status |
| Secondary | Infant Birthweight | time of delivery | Infant Birthweight |
| Secondary | Infant Growth | 9 months of age | Infant height, weight, and age (Weight-for-Age \[WAZ\], Height-for-Age \[HAZ\], Weight-for-Height \[WHZ\] Z-scores). A Z-score of 0 represents the population mean. Indicators of infant malnutrition are defined as Underweight- WAZ Z-score\<-2; Stunting-HAZ Z-Score \<-2; Wasting- WHZ Z-Score \<-2. |
| Secondary | PrEP Use | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | PrEP Utilization by participants |
| Secondary | PrEP Acceptance | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | PrEP accepted by participants |
| Secondary | Preterm Birth | At birth | Birth \<37 weeks gestation |
| Other | PrEP Adherence by Self-report | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Any missed doses in the last month reported by participants |
| Other | Partner on ART if HIV Positive | Enrollment to 9 months postpartum, the median gestational age at enrollment was 24 weeks (IQR: 20, 30). | Participant report of partner ART use if partner is HIV positive |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03070600/registered